4745.TWO Cowealth Medical Holding Co Ltd
- Market cap
- TWD 689M
- P/E
- -
- P/B
- 0.26x
- ROE
- -4.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 4745.TWO undervalued?
Graham numberThe Graham number of Cowealth Medical Holding Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cowealth Medical Holding Co Ltd fundamental analysis
No fundamental analysis for Cowealth Medical Holding Co Ltd yet.
Cowealth Medical Holding Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cowealth Medical Holding Co Ltd
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. The company operates in two segments, Sells Equipment, and Sells Reagents and Others. It is involved in the provision of supply chain management services for reagents and consumables to hospitals; procurement, distribution, and management of reagents and consumables for medical institutions; and send specialis…
Full company profileCowealth Medical Holding Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cowealth Medical Holding Co Ltd annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 3.04B | 3.90B | 4.67B | 4.72B | 5.14B | 5.63B | 4.81B | 4.19B | 2.96B | 3.11B |
| Gross Profit | 787M | 881M | 1.04B | 1.02B | 1.06B | 1.10B | 996M | 792M | 392M | 519M |
| Operating Income | 249M | 358M | 442M | 428M | 388M | 434M | 284M | 91.0M | -180M | -23.1M |
| EBITDA | 389M | 644M | 524M | 536M | 458M | 491M | 339M | 169M | -212M | -134M |
| Net Income | 174M | 286M | 280M | 124M | 139M | 94.1M | 55.7M | 629K | -247M | -112M |
| EPS | 2.17 | 3.70 | 3.61 | 1.61 | 1.80 | 1.21 | 0.72 | 0.01 | -3.18 | -1.68 |
| Balance Sheet | ||||||||||
| Total Assets | 3.63B | 4.09B | 5.41B | 5.38B | 5.40B | 7.21B | 6.64B | 6.96B | 7.04B | 7.19B |
| Total Liabilities | 1.97B | 2.20B | 2.07B | 1.95B | 1.88B | 2.00B | 1.61B | 1.76B | 1.99B | 2.27B |
| Shareholders' Equity | 1.66B | 1.83B | 2.44B | 2.55B | 2.57B | 2.84B | 2.72B | 2.80B | 2.87B | 2.70B |
| Cash & Short-term Investments | 409M | 648M | 1.28B | 1.21B | 843M | 1.43B | 927M | 1.18B | 943M | 589M |
| Total Debt | - | - | - | 985M | 913M | 956M | 647M | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 135M | 134M | -137M | 805M | -118M | -268M | 45.0M | 469M | 15.5M | 15.9M |
| Capital Expenditure | 40.7M | 59.9M | 89.2M | 28.1M | 36.7M | 26.4M | 236M | 62.3M | 14.7M | 8.38M |
| Free Cash Flow | 89.5M | 71.8M | -235M | 777M | -155M | -294M | -191M | 407M | 836K | 7.54M |
| Ratios | ||||||||||
| ROE | 10.4% | 15.6% | 11.4% | 4.9% | 5.4% | 3.3% | 2.0% | 0.0% | -8.6% | -4.1% |
| ROA | 4.8% | 7.0% | 5.2% | 2.3% | 2.6% | 1.3% | 0.8% | 0.0% | -3.5% | -1.6% |
| Net Profit Margin | 5.7% | 7.3% | 6.0% | 2.6% | 2.7% | 1.7% | 1.2% | 0.0% | -8.3% | -3.6% |
| Debt to Equity | - | - | - | 0.39x | 0.36x | 0.34x | 0.24x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cowealth Medical Holding Co Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 27, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | TWD 31.0M | 0.40 | 4,925.3% |
| 2023 | TWD 124M | 1.60 | 222.4% |
| 2022 | TWD 116M | 1.50 | 123.4% |
| 2021 | TWD 92.9M | 1.20 | 66.6% |
| 2020 | TWD 88.5M | 1.14 | 71.2% |
| 2019 | TWD 18.4M | 0.24 | 6.6% |
| 2018 | TWD 11.5M | 0.15 | 4.0% |
| 2017 | TWD 115M | 1.44 | 66.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1050:1000 on Jul 16, 2020.
Who owns Cowealth Medical Holding Co Ltd
- Insiders 50.38%
- Institutions 0.00%
- Public & others 49.62%
- Shares outstanding 66.2M
- Free float 28.0M
Cowealth Medical Holding Co Ltd company profile
- Company name
- Cowealth Medical Holding Co Ltd
- Ticker
- 4745.TWO
- ISIN
- KYG248111042
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- Guangqi Building, Shanghai, China
- Phone
- 86 40 06788855
- Website
- cowealthholding.com
About Cowealth Medical Holding Co Ltd
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. The company operates in two segments, Sells Equipment, and Sells Reagents and Others. It is involved in the provision of supply chain management services for reagents and consumables to hospitals; procurement, distribution, and management of reagents and consumables for medical institutions; and send specialists to assist with tasks, including inventory control, demand forecasting, specialized departmental training, and application of information technology. The company also provides acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision making, multi-channel coaxial-time-audio-video-image digital platform for operating rooms, and cross-strait medical resource platform. In addition, it provides equipment comprising CyberKnife Stereotactic Radiosurgery System, a non-invasive treatment alternative for cancerous and non-cancerous tumors, as well as other medical conditions requiring radiation therapy; LipiView Ocular Surface Interferometer and LipiView Thermal Pulsation System, a system designed to diagnose and address meibomian gland dysfunction; and MRIdian-Linac, an MRI-guided radiation therapy system. Further, the company engages in general investing; import and export medical equipment, reagents, and spare parts; nutrition, health, and social and economic consulting business; and provision of software development, IT equipment maintenance, and IT system maintenance, hospital management, business management, and economic information consulting services. Cowealth Medical Holding Co., Ltd. was founded in 1994 and is headquartered in Shanghai, China.
Cowealth Medical Holding Co Ltd management
2- Mr. Duane LeeFounder & CEO
- Jing TianFinancial Officer & Accounting Officer